SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sensus Healthcare, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.76−0.01 (-0.36%)
Close on Oct 19, 2026
- Market cap
- $45.44M
- P/E (TTM)
- –
- Dividend yield
- –
Sensus Healthcare, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $10.55M | $14.70M | $19.76M | $28.29M | $30.93M | $33.61M | $36.40M | $36.50M | $31.92M | $27.37M | $20.35M | $20.80M | 60.3% | -65.9% |
| Service Revenue [Member] | $3.01M | $3.52M | $3.46M | $3.36M | $3.26M | $3.22M | $3.20M | $3.16M | $3.09M | $2.99M | $2.80M | $2.87M | 17.2% | -7.6% |
| Service [Member] | $2.11M | $2.44M | $2.54M | $2.62M | $2.57M | $2.21M | $1.96M | $1.65M | $1.35M | $1.29M | $1.26M | $1.27M | 12.1% | -18.0% |
| Product Revenue [Member] | $1.83M | $1.87M | $1.72M | $1.33M | $804.00K | – | $247.00K | – | – | – | – | – | 10.5% | +127.7% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $14.83M | $19.75M | $25.36M | $33.60M | $35.90M | $37.85M | $40.18M | $39.51M | $34.26M | $29.49M | $22.28M | $22.68M | 84.7% | -58.7% |
| China | $2.28M | $2.68M | $2.03M | $1.93M | $1.48M | $1.47M | $1.45M | $1.34M | $1.79M | $1.52M | $1.49M | $1.85M | 13.0% | +54.1% |
| Other [Member] | $112.00K | $102.00K | $90.00K | $76.00K | $185.00K | $169.00K | $182.00K | $215.00K | $74.00K | $84.00K | $2.00K | $87.00K | 0.6% | -39.5% |
| Ireland | – | – | – | – | – | – | – | – | – | – | $135.00K | – | – | – |
| Guatemala | – | – | – | – | – | – | – | – | – | – | $190.00K | – | – | – |
| Israel | – | – | – | – | – | – | $172.00K | – | – | – | $43.00K | – | – | – |
From the segment and revenue-disaggregation notes of Sensus Healthcare's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.